Literature DB >> 10068673

Involvement of wiskott-aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway.

Y Baba1, S Nonoyama, M Matsushita, T Yamadori, S Hashimoto, K Imai, S Arai, T Kunikata, M Kurimoto, T Kurosaki, H D Ochs, J i Yata, T Kishimoto, S Tsukada.   

Abstract

Bruton's tyrosine kinase (Btk) has been shown to play a role in normal B-lymphocyte development. Defective expression of Btk leads to human and murine immunodeficiencies. However, the exact role of Btk in the cytoplasmic signal transduction in B cells is still unclear. This study represents a search for the substrate for Btk in vivo. We identified one of the major phosphoproteins associated with Btk in the preB cell line NALM6 as the Wiskott-Aldrich syndrome protein (WASP), the gene product responsible for Wiskott-Aldrich syndrome, which is another hereditary immunodeficiency with distinct abnormalities in hematopoietic cells. We demonstrated that WASP was transiently tyrosine-phosphorylated after B-cell antigen receptor cross-linking on B cells, suggesting that WASP is located downstream of cytoplasmic tyrosine kinases. An in vivo reconstitution system demonstrated that WASP is physically associated with Btk and can serve as the substrate for Btk. A protein binding assay suggested that the tyrosine-phosphorylation of WASP alters the association between WASP and a cellular protein. Furthermore, identification of the phosphorylation site of WASP in reconstituted cells allowed us to evaluate the catalytic specificity of Btk, the exact nature of which is still unknown.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068673

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

Review 1.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 2.  The Wiskott-Aldrich syndrome.

Authors:  A J Thrasher; C Kinnon
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 3.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

4.  BLNK mediates Syk-dependent Btk activation.

Authors:  Y Baba; S Hashimoto; M Matsushita; D Watanabe; T Kishimoto; T Kurosaki; S Tsukada
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

5.  Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.

Authors:  T Yamadori; Y Baba; M Matsushita; S Hashimoto; M Kurosaki; T Kurosaki; T Kishimoto; S Tsukada
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

6.  The N-terminus of Dictyostelium Scar interacts with Abi and HSPC300 and is essential for proper regulation and function.

Authors:  Diana Caracino; Cheryl Jones; Mark Compton; Charles L Saxe
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

7.  Impaired cell adhesion, apoptosis, and signaling in WASP gene-disrupted Nalm-6 pre-B cells and recovery of cell adhesion using a transducible form of WASp.

Authors:  Rikiya Sato; Susumu Iiizumi; Eun-Sung Kim; Fumiko Honda; Sang-Kyou Lee; Noritaka Adachi; Hideki Koyama; Shuki Mizutani; Tomohiro Morio
Journal:  Int J Hematol       Date:  2012-02-05       Impact factor: 2.490

8.  The MARCKS protein plays a critical role in phosphatidylinositol 4,5-bisphosphate metabolism and directed cell movement in vascular endothelial cells.

Authors:  Hermann Kalwa; Thomas Michel
Journal:  J Biol Chem       Date:  2010-11-20       Impact factor: 5.157

9.  Bruton's tyrosine kinase regulates Shigella flexneri dissemination in HT-29 intestinal cells.

Authors:  Ana-Maria Dragoi; Arthur M Talman; Hervé Agaisse
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

10.  NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma.

Authors:  C A Murga-Zamalloa; V Mendoza-Reinoso; A A Sahasrabuddhe; D Rolland; S R Hwang; S R P McDonnell; A P Sciallis; R A Wilcox; V Bashur; K Elenitoba-Johnson; M S Lim
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.